Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of HR19042 capsules for autoimmune hepatitis has completed. The update outlines the trial's efficacy and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• HR19042

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Autoimmune Hepatitis | Phase 2 | Status: COMPLETED